Katsuoka, Yuna
32  results:
?
1

A phase 1/2 study of NS-87/CPX-351 (cytarabine and daunorub..:

Usuki, Kensuke ; Miyamoto, Toshihiro ; Yamauchi, Takuji...
International Journal of Hematology.  119 (2024)  6 - p. 647-659 , 2024
 
?
 
?
6

Advantages of Higher Busulfan Dose Intensity in Fludarabine..:

Shibata, Sho ; Arai, Yasuyuki ; Kondo, Tadakazu...
Transplantation and Cellular Therapy.  29 (2023)  5 - p. 332.e1-332.e11 , 2023
 
?
8

Real-world treatment patterns and clinical outcomes in pati..:

Yoshida, Chikashi ; Kondo, Takeshi ; Ito, Tomoki...
International Journal of Hematology.  116 (2022)  1 - p. 89-101 , 2022
 
?
10

Ideal Body Weight Is Useful For Predicting Neutrophil Engra..:

Okada, Yosuke ; Nakasone, Hideki ; Konuma, Takaaki...
Transplantation and Cellular Therapy.  28 (2022)  8 - p. 504.e1-504.e7 , 2022
 
?
11

Effect of methotrexate dose in graft-versus-host disease pr..:

Terakura, Seitaro ; Kuwatsuka, Yachiyo ; Sugita, Junichi...
International Journal of Hematology.  113 (2021)  6 - p. 840-850 , 2021
 
?
 
?
15

Safety and efficacy of anti-programmed cell death-1 monoclo..:

Ito, Ayumu ; Kim, Sung-Won ; Matsuoka, Ken-ichi...
International Journal of Hematology.  112 (2020)  5 - p. 674-689 , 2020
 
1-15